MCF-7/GFP-scFv1C9 cells have a significantly lower tumourigenicity than MCF-7/GFP cells, suggesting that FGF-1 is important for the development of breast cancer and that blocking FGF-1 with a specific antibody is an effective strategy to inhibit breast cancer. This evidence concerns the gene FGF1 and breast carcinoma.